Page 9 - Vitro Diagnostics News Today

Surmodics (NASDAQ:SRDX – Get Free Report) and Artivion (NYSE:AORT – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, analyst recommendations, dividends, earnings, risk, valuation and institutional ownership. Profitability This table compares Surmodics and Artivion’s net margins, […]

NEW YORK, United States, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled "Triple-Negative Breast Cancer Treatment Market By Drug Type (Cyclophosphamide, Paclitaxel,

BIOMEDevice Boston To Focus on Emerging MedTech Through Innovation ...

Stocks with high liquidity levels have always been in demand, owing to their potential to provide maximum returns.

Surmodics, Inc. (NASDAQ:SRDX – Get Free Report) shares reached a new 52-week high on Monday . The company traded as high as $39.41 and last traded at $38.25, with a volume of 76704 shares. The stock had previously closed at $38.36. Wall Street Analyst Weigh In A number of research analysts recently issued reports on […]

Title21 Enables Single-Source Management of Employee Data Leveraging ...

Dublin, Sept. 06, 2023 (GLOBE NEWSWIRE) -- The

"Major players operating in the Top 10 medical device technologies market Abbott Laboratories, Inc. (US), Roche Diagnostics (Switzerland), Koninklijke Philips N.V. (Netherlands), Siemens Healthineers (Germany)"Browse 409

COVID-19 created unprecedented demand for in vitro diagnostic expertise and products, and Kalorama Informations latest market research report pro...

/PRNewswire/ -- In vitro diagnostics (IVDs) remain dynamic. The IVD market is a high R&D spend industry with constant innovations and routine interest from...